ArticleACG case reports journal2026
Extranodal Rosai-Dorfman Disease Presenting as a Pancreatic Mass Associated With Superior Mesenteric Artery Thrombosis.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rosai-Dorfman disease (RDD) is a rare, nonmalignant histiocytic disease that classically presents as bulky lymphadenopathy. Although RDD can be seen in various organ systems, gastrointestinal involvement is uncommon. We present a case of RDD involving the pancreatic head causing biliary obstruction, arterial thrombus, abdominal pain, and concern for malignancy. Endoscopic ultrasound and pancreas biopsy demonstrated a mass without malignant features and pathological features including benign pancreatic parenchyma, noncaseating granulomas, and mixed acute and chronic inflammation including histiocytes with emperipolesis and a staining pattern that confirmed a diagnosis of RDD. She experienced symptom relief and reduced mass size and metabolic activity after treatment with cobimetinib. When there is uncertainty surrounding the etiology of a slow-growing pancreatic mass with atypical features, the differential diagnosis should include uncommon causes such as RDD and may warrant evaluation in a tertiary referral center to avoid extensive and unnecessary surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.